Position in AZN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,393,483,154
New position
Shares Held
7,065,628
first reported quarter
Ownership
0.456%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 50.54784939144829.ToString("F0")%
Shared 0.ToString("F0")%
None 49.45215060855171.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Sanders Capital, LLC holds $1,505,836,965 across 2 Drug Manufacturers - General names. AZN ranks #1 (92.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
7,065,628 | $1,393,483,154 | |
| 2 | ABBV |
AbbVie Inc.
|
516,593 | $112,353,811 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,393,483,154 | 7,065,628 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||